Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Glycosaminoglycan degradation	5/19	1.016165671792888e-11	9.145491046135993e-11	575.2857142857143	-745.3105240186693	GNS;HGSNAT;IDS;NAGLU;SGSH
KEGG_2021_Human	Lysosome	6/128	2.806581391919395e-09	1.2629616263637279e-08	97.69672131147541	-290.9287426236646	GNS;HGSNAT;IDS;NAGLU;SGSH;SUMF1
KEGG_2021_Human	Glycosaminoglycan biosynthesis	3/53	3.098408218261013e-05	9.29522465478304e-05	68.72571428571429	-119.39488334977806	EXT2;EXTL2;EXTL3
KEGG_2021_Human	Hepatocellular carcinoma	1/168	0.18964573513289215	0.3793649174026261	5.256819693945443	-2.919648521708157	IGF2
KEGG_2021_Human	Proteoglycans in cancer	1/205	0.22678373523038298	0.3793649174026261	4.283224400871459	-2.2275706216550177	IGF2
KEGG_2021_Human	Ras signaling pathway	1/232	0.25290994493508406	0.3793649174026261	3.7696007696007694	-1.8563524399324505	IGF2
KEGG_2021_Human	MAPK signaling pathway	1/294	0.3099217585428667	0.39847083241225717	2.9484262419416005	-1.2588658824557653	IGF2
KEGG_2021_Human	PI3K-Akt signaling pathway	1/354	0.36133488698431165	0.40650174785735066	2.4283915643689014	-0.883914601009246	IGF2
KEGG_2021_Human	Pathways in cancer	1/531	0.4935522426966286	0.4935522426966286	1.580293501048218	-0.3089273055464	IGF2
